How the Lysophospholipid Got its Receptor

How the Lysophospholipid Got its Receptor The discovery of a new family of lipid receptors provides potential targets for diseases such as multiple sclerosis and autoimmunity. By Jerold Chun Related Articles 1 By the late 1960s, researchers had become aware that this somewhat obscure class of lipids had the remarkable ability to act like an extracellular signaling molecule.2 Two prominent forms typify but do not limit lysophospholipids: lysophosphatidic acid

| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

By Jerold Chun

1 By the late 1960s, researchers had become aware that this somewhat obscure class of lipids had the remarkable ability to act like an extracellular signaling molecule.2 Two prominent forms typify but do not limit lysophospholipids: lysophosphatidic acid (LPA), which is derived from glycerophospholipids such as phosphatidyl serine or phosphatidyl choline (known commonly as lecithin, as in egg yolk); and sphingosine 1-phosphate (S1P), which is derived from sphingolipids such as sphingomyelin, ceramide, and sphingosine.

Although rare compared to most membrane lipids, they could be found in relatively high concentrations (micromolar) within blood plasma and/or serum. How these lysophospholipids worked was unclear and much debated in the decade preceding the mid-1990s, with explanations invoking lysophospholipids as membrane disruptors (lysophospholipids look a bit like detergents), second messengers, ionophores, calcium chelators, as well as ligands for intracellular and extracellular receptors.

"We had found a gene and the GPCR it encoded, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jerold Chun

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo